Shadd Dales is the Founder and President of The Dales Report. With over 15 years of experience in the business media industry, he specializes in cannabis and psychedelics, finance, and trading, focusing on topics such as cannabis business and regulation. Shadd's insights and expertise have been featured in Benzinga, The Dales Report, and The Business Herald.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
Global cannabis industry expert and consultant Deepak Anand joins to demystify the DEA-application and cannabis export question.
Shadd Dales and Anthony Varrell continue earnings-season coverage, digging into the Jushi Q2 print with Chairman and CEO Jim Cacioppo.
FundCanna founder and CEO Adam Stettner joins to break down earnings season based on what the first prints of the post-rescheduling era are actually telling us.
TerrAscend Executive Chairman Jason Wild and CEO Ziad Ghanem open the show, and Edibles President Thomas Winstanley returns to tackle the hemp fight.
Shadd Dales and Anthony Varrell continue their earnings-season coverage as M&A momentum builds. High Tide founder and CEO Raj Grover joins for segment one to discuss preliminary Q3 numbers.
In the latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell kick things off with stories out of Washington and Michigan before shifting into an options-market breakdown on MSOS, with day trader Andrew O’Connell of the Pristine Capital Substack. First, the policy front. Congressional researchers are again calling out the […]
podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell welcome Sean Karl of Vantage Hemp to discuss AI in cannabis. FundCanna CEO Adam Stettner then joins, fresh off the PBC Conference in Washington, to discuss banks and lending to cannabis operations.
podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down DEA Chief Administrative Law Judge Derek Julius's decision to pause the marijuana rescheduling hearing. Opponents had moved to add a new Government Accountability Office report to the record.
“When will the institutions show up?” They're already here. Trulieve Cannabis has crossed a threshold long closed to most U.S. plant-touching cannabis operators, securing a place in the machinery of passive investing after its June listing on the New York Stock Exchange. The move followed federal rescheduling of medical marijuana to Schedule III and the company's redomicile to Delaware, clearing the principal obstacles that had kept such firms confined to over-the-counter markets and specialized thematic funds. By mid-September, Trulieve had been added to the S&P Total Market Index and the S&P Completion Index. Those inclusions have already produced measurable ownership in several of the largest broad-market and completion-index trackers, illustrating how quickly rules-based capital can respond once listing and domicile requirements are satisfied.
In today's Trade To Black podcast presented by Flowhub, Shadd Dales and Anthony Varrell get a sneak preview of earnings season, starting with preliminary Q3 results from Glass House Brands. We also cover the escalating fight between Curaleaf and Aurora Cannabis, and Michael Bronstein, president of the American Trade Association for Cannabis and Hemp, returns for his weekly Insiders Edge segment ahead of a key week in the DEA rescheduling hearing.
